Flagship Pioneering, LLC

Holdings History for Foghorn Therapeutics Inc. - Common Stock, $0.0001 par value per share (FHTX)

Symbol: FHTX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	21%	0%	$68,440,247	12,674,120	$5.40	Q4 2025
30 Sep 2025	21%	0%	$61,976,446	12,674,120	$4.89	Q3 2025
30 Jun 2025	22%	0%	$59,568,365	12,674,120	$4.70	Q2 2025
31 Mar 2025	20%	0%	$46,260,539	12,674,120	$3.65	Q1 2025
31 Dec 2024	18%	0%	$59,821,847	12,674,120	$4.72	Q4 2024
30 Sep 2024	20%	0%	$117,996,057	12,674,120	$9.31	Q3 2024
30 Jun 2024	8.6%	0%	$72,876,191	12,674,120	$5.75	Q2 2024
31 Mar 2024	5.6%	0%	$85,043,345	12,674,120	$6.71	Q1 2024
31 Dec 2023	6.2%	0%	$81,748,073	12,674,120	$6.45	Q4 2023
30 Sep 2023	4.6%	0%	$63,370,600	12,674,120	$5.00	Q3 2023
30 Jun 2023	4%	0%	$89,225,805	12,674,120	$7.04	Q2 2023
31 Mar 2023	3.1%	0%	$78,579,544	12,674,120	$6.20	Q1 2023
31 Dec 2022	2.8%	0%	$80,860,886	12,674,120	$6.38	Q4 2022
30 Sep 2022	4.6%	0%	$108,744,000	12,674,120	$8.58	Q3 2022
30 Jun 2022	6.5%	0%	$172,368,000	12,674,120	$13.60	Q2 2022
31 Mar 2022	4.5%	0%	$193,027,000	12,674,120	$15.23	Q1 2022
31 Dec 2021	4.5%	0%	$289,857,000	12,674,120	$22.87	Q4 2021
30 Sep 2021		0%	$176,551	12,674,120	$0.01 ^*	Q3 2021
30 Jun 2021		0%	$135,233	12,674,120	$0.01 ^*	Q2 2021
31 Mar 2021		0%	$167,045	12,674,120	$0.01 ^*	Q1 2021
31 Dec 2020		0%	$256,905	12,674,120	$0.02 ^*	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.